-
Study aim
-
The effectiveness of Neurofeedback and Heart Rate Variability Training on QEEG Baseline and Sustained Attention in Children with ADHD
-
Design
-
Randomized Controlled Trial
-
Settings and conduct
-
For monitoring treatment progression and clinical outcome, before and after the study and a 6-month follow-up examination; the relations between baseline difference in quantitative electroencephalography, continuous performance testing and Connors rating scale of parents will be determined.
-
Participants/Inclusion and exclusion criteria
-
Children with Attention Deficit/Hyperactivity Disorder (ADHD), who are 7 to 12 years old, with definite diagnosis by a psychiatrist, based on DSM-V diagnostic criteria, semi-structured interview and developmental history; referred to the Psychiatric Clinic of Yahya Nejad Hospital and Private Center for Psychiatric Disorders. These criteria are based on such factors as co-occurrence of ADHD with other psychiatric and neurological disorders, mental retardation, as well as parents informed consent who agreed to allow their children to participate
-
Intervention groups
-
Eighty children with ADHD randomly divide into five experimental groups, namely a Neurofeedback (NFB) Group, two distinct theta/beta ratio and theta/sensorimotor rhythm training NFB protocols for a cumulative total of 30 minutes (15 minutes each) or more over a 45 minutes' period in 30 sessions/12 weeks, and Neurofeedback/ Biofeedback (BFB) Group, heart rate variability and respiratory BFB Group in which participants encouraged to breathe slowly and diaphragmally for 3-5 minutes, adapting inhalation and exhalation to heart rate fluctuations, and the other Methylphenidate, twice-a-day oral administration contains 5 mg which may be increased in 10 mg increments at weekly intervals, and Methylphenidate along with Neurofeedback and NeuroBiofeedback Groups.
-
Main outcome variables
-
Baseline QEEG; Attention, Impulsivity